General Pharmaceuticals Market Research Reports & Industry Analysis
General Pharmaceuticals Industry Research & Market Reports
-
Isosorbide
... 7.4% over the analysis period 2024-2030. PEIT, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$439.5 Million by the end of the analysis period. Growth in ... Read More
-
Medical Marijuana
... CAGR of 14.4% over the analysis period 2024-2030. Extract Form, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$60.5 Billion by the end of the analysis ... Read More
-
Curcumin
... 8.5% over the analysis period 2024-2030. Pharmaceuticals, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$73.0 Million by the end of the analysis period. Growth in ... Read More
-
Empty Capsules
... CAGR of 5.5% over the analysis period 2024-2030. Gelatin, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$3.5 Billion by the end of the analysis period. ... Read More
-
Excipients
... 4.6% over the analysis period 2024-2030. Polymers, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$4.4 Billion by the end of the analysis period. Growth in ... Read More
-
Pharmaceutical Excipients
... CAGR of 4.5% over the analysis period 2024-2030. Organic Chemicals, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$9.8 Billion by the end of the analysis ... Read More
-
Carglumic Acid
... CAGR of 5.3% over the analysis period 2024-2030. Orally Disintegrating Tablets, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$105.6 Million by the end of the ... Read More
-
Medical Membranes
... CAGR of 7.7% over the analysis period 2024-2030. Ultrafiltration, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$2.0 Billion by the end of the analysis period. ... Read More
-
Track Etched Membranes
... at a CAGR of 10.1% over the analysis period 2024-2030. Membrane Filters, one of the segments analyzed in the report, is expected to record a 11.2% CAGR and reach US$855.4 Million by the end of ... Read More
-
Constipation Treatment
... CAGR of 5.9% over the analysis period 2024-2030. Laxatives, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$12.3 Billion by the end of the analysis period. ... Read More
-
Triacetin
... 4.3% over the analysis period 2024-2030. Plasticizer, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$193.2 Million by the end of the analysis period. Growth in ... Read More
-
Anti-Ischemic Agents
... CAGR of 6.3% over the analysis period 2024-2030. The U.S. Market is Estimated at US$94.1 Million While China is Forecast to Grow at 9.7% CAGR The Anti-Ischemic Agents market in the U.S. is estimated at ... Read More
-
Potassium Bromide
... CAGR of 4.2% over the analysis period 2024-2030. The U.S. Market is Estimated at US$8.5 Million While China is Forecast to Grow at 7.8% CAGR The Potassium Bromide market in the U.S. is estimated at ... Read More
-
Sodium Bromide
... CAGR of 6.2% over the analysis period 2024-2030. Powder, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$1.7 Billion by the end of the analysis period. ... Read More
-
Synthetic Antioxidants
... CAGR of 6.1% over the analysis period 2024-2030. Liquid, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$2.4 Billion by the end of the analysis period. ... Read More
-
Aseptic Sampling
... CAGR of 10.0% over the analysis period 2024-2030. Off-line, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$251.8 Million by the end of the analysis period. ... Read More
-
Astaxanthin
... 6.8% over the analysis period 2024-2030. Synthetic, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$593.9 Million by the end of the analysis period. Growth in ... Read More
-
Binder Excipients
... CAGR of 5.3% over the analysis period 2024-2030. Cellulosics, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$1.0 Billion by the end of the analysis period. ... Read More
-
Calcium Gluconate
... CAGR of 6.1% over the analysis period 2024-2030. Powder, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$64.7 Million by the end of the analysis period. ... Read More
-
Cannabis Testing
... CAGR of 12.9% over the analysis period 2024-2030. Cannabis Cultivators / Growers, one of the segments analyzed in the report, is expected to record a 12.3% CAGR and reach US$1.9 Billion by the end of ... Read More
-
Glucose, Dextrose, and Maltodextrin
... 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Glucose, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$32.3 Billion by the end ... Read More
-
Insoluble Dietary Fibers
... at a CAGR of 8.0% over the analysis period 2024-2030. Cellulose, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$1.9 Billion by the end of the ... Read More
-
Lifestyle Drugs
... CAGR of 3.1% over the analysis period 2024-2030. Obesity, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$21.4 Billion by the end of the analysis period. ... Read More
-
Nutraceutical Excipients
... CAGR of 6.2% over the analysis period 2024-2030. Binders, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$2.4 Billion by the end of the analysis period. ... Read More
-
RFID Smart Cabinets
... at a CAGR of 9.8% over the analysis period 2024-2030. The U.S. Market is Estimated at US$272.7 Million While China is Forecast to Grow at 9.1% CAGR The RFID Smart Cabinets market in the U.S. ... Read More
Research Assistance
